iA Global Asset Management Inc.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1969566
Quebec, A8
Position in ALNY
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$5,268,112
-$1,802,105 QoQ
Shares Held
15,922
-10.4% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026iA Global Asset Management Inc. holds $65,686,645 across 11 Biotechnology names. ALNY ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,646 | $15,951,925 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,915 | $13,804,784 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
123,212 | $6,057,101 | |
| 4 | INSM |
INSMED Inc
|
34,977 | $5,719,439 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
15,922 | $5,268,112 | |
| 6 | ARGX |
Argenx SE
|
6,000 | $4,381,500 | |
| 7 | IRON |
Disc Medicine, Inc.
|
66,243 | $4,235,577 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
215,830 | $4,219,476 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,268,112 | 15,922 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $7,070,217 | 17,780 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $751,032 | 1,647 | Shares | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||